Dementia most commonly affects people over a certain age, but early onset Alzeimher’s has been known to affect the lives of people in their mere 30s and 40s.
Scientists are currently celebrating new medical drug Lecanemab, which could be a potential game changer for the treatment of the disease. The drug has been given intravenously in clinical trials, proving that the drug can moderately slow down the rate of cognitive decline in early stage Alzeimher’s patients.
Experts say that although memory change over time is both common and natural, there are certain symptoms specific to Alzeimher’s that are worth paying extra attention to. Changes in mood or behaviour, difficulties understanding time or space and a marked difference in visual observation can indicate Alzeimher’s.
